Zhangjiang Torch Venture Capital Co

Zhangjiang Torch Venture Capital Co is an early- and growth-stage venture capital firm founded in November 2008 as the dedicated investment arm of Zhangjiang High Tech Park Group, the operating entity behind Shanghai's flagship Zhangjiang Hi-Tech Park in Pudong, a national-level science park known as 'China's Medicine Valley' for its dense concentration of biotech, pharmaceutical, semiconductor and advanced-manufacturing companies. The fund concentrates on the strategic sectors that Zhangjiang Hi-Tech Park is built to nurture: integrated circuits and application-specific semiconductors, next-generation information technology, biomedicine and high-performance medical devices, intelligent manufacturing, and new-energy and advanced-materials technologies, generally as a co-investor. Typical deal sizes have been reported in the $5M to $10M range, and across the fund's life it has made approximately 64 disclosed investments. Notable portfolio companies include Yanwei Semiconductor, its most recent reported investment in July 2023, Shengfang Technology, Xinyu New Material, Aqbiopharma and SeeYA Technology, its latest reported portfolio exit in March 2026. Public databases describe the entity as permanently closed at the original Zhangjiang Torch level, with the broader Zhangjiang state-affiliated venture activity continuing under related vehicles such as Zhangjiang Hi-Tech Investment, Zhangjiang Haocheng and ZJ Innopark, which remained active through 2025 to 2026. Fund leadership ties back to the Zhangjiang High Tech Park Group rather than named external GPs. As the investment arm of one of China's leading science parks, Zhangjiang Torch Venture Capital backed semiconductor, biomedicine, intelligent-manufacturing and advanced-materials companies aligned with the park's strategic sectors.